Your browser doesn't support javascript.
loading
Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab.
Nindra, Udit; Shahnam, Adel; Stevens, Samuel; Pal, Abhijit; Nagrial, Adnan; Lee, Jenny; Yip, Po Yee; Adam, Tamiem; Boyer, Michael; Kao, Steven; Bray, Victoria.
Affiliation
  • Nindra U; Department of Medical Oncology, Liverpool Hospital, Liverpool, Australia.
  • Shahnam A; Department of Medical Oncology, Westmead Hospital, Sydney, Australia.
  • Stevens S; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia.
  • Pal A; Department of Medical Oncology, Liverpool Hospital, Liverpool, Australia.
  • Nagrial A; Department of Medical Oncology, Westmead Hospital, Sydney, Australia.
  • Lee J; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia.
  • Yip PY; Department of Clinical Medicine, Macquarie University, Sydney, Australia.
  • Adam T; Department of Medical Oncology, Macarthur Cancer Therapy Centre, Campbelltown Hospital, Campbelltown, Australia.
  • Boyer M; School of Medicine, Western Sydney University, Sydney, Australia.
  • Kao S; Department of Medical Oncology, Bankstown-Lidcombe Hospital, Sydney, Australia.
  • Bray V; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia.
Asia Pac J Clin Oncol ; 20(1): 16-24, 2024 Feb.
Article in En | MEDLINE | ID: mdl-36855021

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antibodies, Monoclonal Type of study: Observational_studies Limits: Humans Language: En Journal: Asia Pac J Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Australia Country of publication: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antibodies, Monoclonal Type of study: Observational_studies Limits: Humans Language: En Journal: Asia Pac J Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Australia Country of publication: Australia